178 related articles for article (PubMed ID: 38275991)
1. Dual Role of Vitamin C-Encapsulated Liposomal Berberine in Effective Colon Anticancer Immunotherapy.
Mianowska M; Zaremba-Czogalla M; Zygmunt A; Mahmud M; Süss R; Gubernator J
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38275991
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Anticancer Potency of a 13-Substituted Berberine Derivative with Cationic Liposomes.
Apiratikul N; Sriklung K; Dolsophon K; Thamvapee P; Watanapokasin R; Yingyongnarongkul BE; Niyomtham N; Bremner JB; Watanavetch P; Samosorn S
Chem Pharm Bull (Tokyo); 2022 Jun; 70(6):420-426. PubMed ID: 35342147
[TBL] [Abstract][Full Text] [Related]
3. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.
Allijn IE; Czarny BMS; Wang X; Chong SY; Weiler M; da Silva AE; Metselaar JM; Lam CSP; Pastorin G; de Kleijn DPV; Storm G; Wang JW; Schiffelers RM
J Control Release; 2017 Feb; 247():127-133. PubMed ID: 28065862
[TBL] [Abstract][Full Text] [Related]
4. Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model.
Lin YC; Kuo JY; Hsu CC; Tsai WC; Li WC; Yu MC; Wen HW
Int J Pharm; 2013 Jan; 441(1-2):381-8. PubMed ID: 23220078
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
Yahuafai J; Asai T; Oku N; Siripong P
Biol Pharm Bull; 2018; 41(7):1103-1106. PubMed ID: 29962406
[TBL] [Abstract][Full Text] [Related]
6. Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines - in vitro studies.
Legut M; Lipka D; Filipczak N; Piwoni A; Kozubek A; Gubernator J
Int J Nanomedicine; 2014; 9():653-68. PubMed ID: 24489469
[TBL] [Abstract][Full Text] [Related]
7. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
[TBL] [Abstract][Full Text] [Related]
8. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
9. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
[TBL] [Abstract][Full Text] [Related]
10. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
11. Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity.
Yang Z; Zhao L; Wang X; He Z; Wang Y
AAPS PharmSciTech; 2021 Jan; 22(1):46. PubMed ID: 33442785
[TBL] [Abstract][Full Text] [Related]
12. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
Hsu WH; Hsieh YS; Kuo HC; Teng CY; Huang HI; Wang CJ; Yang SF; Liou YS; Kuo WH
Arch Toxicol; 2007 Oct; 81(10):719-28. PubMed ID: 17673978
[TBL] [Abstract][Full Text] [Related]
13. In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach.
Al-Asmari AK; Ullah Z; Al Balowi A; Islam M
Int J Nanomedicine; 2017; 12():559-574. PubMed ID: 28144138
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
[TBL] [Abstract][Full Text] [Related]
15. Liposomes in the treatment of malignancy: a clinical perspective.
Sugarman SM; Perez-Soler R
Crit Rev Oncol Hematol; 1992; 12(3):231-42. PubMed ID: 1497823
[TBL] [Abstract][Full Text] [Related]
16. The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells.
Chidambara Murthy KN; Jayaprakasha GK; Patil BS
Eur J Pharmacol; 2012 Aug; 688(1-3):14-21. PubMed ID: 22617025
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes.
Oudard S; Thierry A; Jorgensen TJ; Rahman A
Cancer Chemother Pharmacol; 1991; 28(4):259-65. PubMed ID: 1678995
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
[TBL] [Abstract][Full Text] [Related]
19. Berberine induces SOCS1 pathway to reprogram the M1 polarization of macrophages via miR-155-5p in colitis-associated colorectal cancer.
Ling Q; Fang J; Zhai C; Huang W; Chen Y; Zhou T; Liu Y; Fang X
Eur J Pharmacol; 2023 Jun; 949():175724. PubMed ID: 37059377
[TBL] [Abstract][Full Text] [Related]
20. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages.
Bartneck M; Peters FM; Warzecha KT; Bienert M; van Bloois L; Trautwein C; Lammers T; Tacke F
Nanomedicine; 2014 Aug; 10(6):1209-20. PubMed ID: 24607939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
